Auto Amazon Links: No products found. Blocked by captcha.
In light of recent guidance from the National Institute for Health and Care Excellence (NICE), individuals who discontinue obesity injections like Wegovy and Mounjaro are advised to undergo regular check-ups for a minimum of one year to prevent weight regain. Many individuals tend to regain the weight they had lost once they cease treatment, as noted by previous experiences. The emphasis on long-term weight management is highlighted in the new advice, which cautions against viewing weight loss as a quick fix.
Statistics reveal that approximately one in four adults in England are impacted by obesity. While an estimated 1.5 million individuals in the UK are using weight loss injections, the majority pay for these treatments privately and will not qualify for NHS assistance upon cessation of the injections. Wegovy, available on NHS prescription, is restricted to those with severe weight-related health issues and a high BMI for a two-year period. On the other hand, approximately 240,000 individuals are anticipated to receive Mounjaro over the next three years without any specified time limit for prescription.
Both drugs, Wegovy and Mounjaro, facilitate reduced appetite and significant weight loss, transforming lives when combined with dietary and physical activity modifications. Studies indicate that individuals participating in drug trials usually regain a substantial portion of their initial weight post-treatment. NICE’s updated recommendations stress the importance of establishing long-term behavioral patterns, utilizing self-monitoring tools, and seeking support from diverse sources such as online communities and family-led interventions.
Professor Jonathan Benger from NICE emphasized the significance of structured support post-treatment to maintain positive changes and prevent weight regain. Similarly, Professor Kamila Hawthorn from the Royal College of GPs underscored the necessity for individualized approaches to address obesity, as what works for one patient may not be effective for another. Prevention strategies are also essential to reduce the need for medical interventions in the future and mitigate the risks associated with obesity, such as heart disease, type 2 diabetes, and certain cancers
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found. Blocked by captcha.